Ken Griffin Kiniksa Pharmaceuticals, Ltd. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$17.63 - $21.74 $1.93 Million - $2.38 Million
-109,406 Reduced 50.96%
105,290 $2.08 Million
Q4 2023

Feb 14, 2024
BUY
$14.37 - $19.07 $1.91 Million - $2.53 Million
132,658 Added 161.7%
214,696 $3.77 Million
Q3 2023

Nov 14, 2023
SELL
$13.62 - $20.2 $1.63 Million - $2.42 Million
-119,796 Reduced 59.35%
82,038 $1.43 Million
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $762,349 - $1.2 Million
73,022 Added 56.69%
201,834 $2.84 Million
Q1 2023

May 15, 2023
SELL
$10.7 - $15.79 $944,681 - $1.39 Million
-88,288 Reduced 40.67%
128,812 $1.39 Million
Q4 2022

Feb 14, 2023
BUY
$11.42 - $17.05 $181,258 - $270,617
15,872 Added 7.89%
217,100 $3.25 Million
Q3 2022

Nov 14, 2022
SELL
$9.76 - $13.41 $1.55 Million - $2.13 Million
-159,181 Reduced 44.17%
201,228 $2.58 Million
Q2 2022

Aug 15, 2022
BUY
$7.6 - $11.41 $887,368 - $1.33 Million
116,759 Added 47.92%
360,409 $3.49 Million
Q1 2022

May 16, 2022
BUY
$9.3 - $12.37 $1.64 Million - $2.18 Million
175,865 Added 259.45%
243,650 $2.42 Million
Q4 2021

Feb 14, 2022
BUY
$10.39 - $15.15 $437,938 - $638,572
42,150 Added 164.42%
67,785 $797,000
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $1.09 Million - $1.56 Million
-95,849 Reduced 78.9%
25,635 $292,000
Q2 2021

Aug 16, 2021
SELL
$13.22 - $19.09 $11.9 Million - $17.2 Million
-900,239 Reduced 88.11%
121,484 $1.69 Million
Q1 2021

May 17, 2021
SELL
$16.68 - $23.97 $717,423 - $1.03 Million
-43,011 Reduced 4.04%
1,021,723 $18.9 Million
Q4 2020

Feb 16, 2021
SELL
$14.8 - $21.15 $180,708 - $258,241
-12,210 Reduced 1.13%
1,064,734 $18.8 Million
Q3 2020

Nov 16, 2020
BUY
$15.21 - $25.53 $5.62 Million - $9.44 Million
369,737 Added 52.28%
1,076,944 $16.5 Million
Q2 2020

Aug 14, 2020
BUY
$15.08 - $26.0 $2.79 Million - $4.81 Million
185,015 Added 35.43%
707,207 $18 Million
Q1 2020

May 15, 2020
BUY
$11.0 - $19.76 $1.72 Million - $3.08 Million
155,935 Added 42.58%
522,192 $8.08 Million
Q4 2019

Feb 14, 2020
SELL
$5.24 - $12.96 $12,224 - $30,235
-2,333 Reduced 0.63%
366,257 $4.05 Million
Q3 2019

Nov 14, 2019
SELL
$8.15 - $15.88 $30,130 - $58,708
-3,697 Reduced 0.99%
368,590 $3.14 Million
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.39 $3.25 Million - $5.02 Million
246,442 Added 195.83%
372,287 $5.04 Million
Q1 2019

May 15, 2019
BUY
$15.93 - $26.59 $1.43 Million - $2.38 Million
89,628 Added 247.47%
125,845 $0
Q4 2018

Feb 14, 2019
SELL
$16.25 - $28.09 $282,360 - $488,091
-17,376 Reduced 32.42%
36,217 $1.02 Million
Q3 2018

Nov 13, 2018
SELL
$13.23 - $30.93 $476,584 - $1.11 Million
-36,023 Reduced 40.2%
53,593 $0
Q2 2018

Aug 10, 2018
BUY
$16.73 - $20.35 $1.5 Million - $1.82 Million
89,616 New
89,616 $0

Others Institutions Holding KNSA

# of Institutions
11
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $878M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email